Interactive cases

Interactive case studies designed to improve your knowledge of adult GHD and to guide you in the management of GHD patients in your clinical practice.

Subtitles available: English, Spanish, French, Portuguese, and Simplified Chinese

Patient case study 1

This case study module, led by program director Beverly MK Biller, follows a young adult previously diagnosed with childhood-onset GHD who halted GH replacement therapy, and focusses on how to recognize and manage these patients in clinical practice.

Patient case study 2

This case study module, led by Michael Buchfelder, follows an adult who has developed GHD after undergoing pituitary surgery, and shares best practice on monitoring and managing these patients.

Patient case study 3

This case study module, led by Stephanie Baldeweg, follows an adult who has developed GHD as a consequence of suffering head trauma, and focusses on how to recognize and manage these patients in clinical practice.

Faculty

Program Chair

Beverly MK Biller

Professor of Medicine at Harvard Medical School (HMS), USA

Faculty member in the Neuroendocrine & Pituitary Tumor Clinical Center at Massachusetts General Hospital (MGH) in Boston, Massachusetts, USA

Dr. Biller is Program Director of the Clinical Fellowship in Adult Endocrinology and Metabolism at MGH. She also directs the annual HMS & MGH Continuing Medical Education course “Clinical Endocrinology” that welcomes endocrinologists from around the world to Boston every Spring.

Major research interests include the diagnosis and treatment of Cushing’s disease, acromegaly, prolactinomas, and growth hormone deficiency (GHD) in adults. Dr. Biller has published original research in many peer-reviewed journals and has co-authored clinical guidelines regarding Cushing’s disease for the Endocrine and Pituitary Societies, on pituitary adenomas in pregnancy for the European Society of Endocrinology and on adult GHD for the American Association of Clinical Endocrinologists.

Disclosures

Dr. Biller discloses a grant received from Ascendis, consulting/Honoraria from Merck Serono and consulting honoraria from Novo Nordisk.

All relevant financial relationships have been mitigated.

Faculty Member

Michael Buchfelder

Chairman of the Department of Neurosurgery, University of Erlangen-Nuremburg, Germany

Previously Professor and Chairman at the Department of Neurosurgery at the University of Gottingen, Germany

Following medical studies at the Ludwig-Maximilians –University in Munich, he received almost all of his neurological training with Professor Rudolf Fahlbusch, with whom he shared a very close long-term cooperation. Prof. Buchfelder enjoys membership of several scientific organisations, such as the German society of Neurosurgery, the German society of skull base surgery, the European Neuroendocrine Association, the US Endocrine Society, as well as the American Association and Congress of Neurological Surgeons. He has a strong dedication and interest in Neuroendocrinology. He served as Congress President of the Annual Meeting of the German Society of Endocrinology in 2007. He is a member of the editorial boards of Central European Neurosurgery, Acta Endocinologica, the journal of the Endocrine Society and as an Editor of Neurosurgical Reviews. He enjoys honorary membership of several National and International scientific organisations and societies.

Prof. Buchfelder’s areas of research include the pathophysiology, diagnosis and treatment of pituitary and hypothalamic tumours and hormonal disturbances associated with cerebral lesions. He is also particularly interested in imaging of pituitary lesions and performed the central reading of MR images within AcroStudy and Seismic.

Disclosures

Prof Buchfelder has lectured for Pfizer and discloses he is currently involved in a study with Crinetics.

All relevant financial relationships have been mitigated.

Faculty Memeber

Prof Stephanie Baldeweg

Consultant Endocrinologist, Department of Diabetes & Endocrinology, UCLH
Clinical Lead, Department of Diabetes & Endocrinology, UCLH

Honorary Professor, Centre for Obesity & Metabolism, Department of Experimental & Translational Medicine, Division of Medicine, UCL

Professor Stephanie Baldeweg works as a Consultant Physician in Diabetes and Endocrinology at University College London Hospital and as Honorary Professor at the Centre for Obesity and Metabolism, Department of Experimental and Translational Medicine, at University College London. She is Clinical Lead of the Department of Diabetes and Endocrinology at UCLH. She graduated from Humboldt University Berlin in 1990 and was awarded her MD on “Insulin resistance and endothelial function in health and type 2 diabetes” in 2002 in London. She was elected Fellow of the Royal College of Physicians of Ireland and of the Royal College of Physicians in London (FRCP) in 2009.

Professor Baldeweg has held a number of National Roles including Associate Academic Dean, Health Education England and Associate Director for Higher Specialties Training, UCL Partners. She is chair of the Clinical Committee, UK Society for Endocrinology and chair of the Joint Specialty Committee for Endocrinology and Diabetes at the Royal College of Physicians.

Professor Baldeweg is interested in all aspects of diabetes and endocrinology. She has a special clinical and research interest in pituitary disease, traumatic brain injury, menopause, transition, general endocrinology and late effects. Her main academic interest aims to improve patient care through systematic clinical research with a focus on cross-specialty working and comorbidities. She has published widely on endocrinological topics, particularly on pituitary disease and is a member of the British Neurotrauma Group and a co-author on the national guidance for The screening and management of pituitary dysfunction following traumatic brain injury in adults.

Prof Baldeweg is a keen medical educator and regularly lectures at national and international meetings as well as Patient days for UK charities.

Disclosures

Stephanie Baldeweng has no financial / non-financial relationships of conflicts of interest to declare.

Accreditation

In support of improving patient care, this activity has been planned and implemented by HMP Education and Springer Healthcare IME. HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

HMP Education designates AMA PRA Category Credit(s)™ for the following activities:

Physicians

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning committee

In addition to the speaker faculty, HMP Education and Springer Healthcare IME planners and staff include Randy Robin, Rachel Goddard & Alba Ruzafa. 

Randy Robbin, Rachel Goddard and Alba Ruzafa have no financial relationships to disclose.